Use Options For a Chance To Buy VRX at a 47% Discount
April 30, 2015 at 11:43 AM EDT
Looking back to 44 days ago, Valeant Pharmaceuticals International Inc (VRX) priced a 7,286,432 share secondary stock offering at $199.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Thursday, the stock is now 6.9% higher than the offering price..